Article

Comprehensive suppression of the renin-angiotensin-aldosterone system in chronic kidney disease: covering all of the bases.

Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana 46202, USA.
Kidney International (Impact Factor: 8.52). 01/2007; 70(12):2051-3. DOI: 10.1038/sj.ki.5002007
Source: PubMed

ABSTRACT Reducing proteinuria and blood pressure in chronic kidney disease (CKD) decreases rate of progression. Inhibition of the renin-angiotensin system by angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers is beneficial in reducing proteinuria but incomplete in suppressing aldosterone production and its renal effects. Adding aldosterone receptor blockers to these other agents may further halt the progression of CKD.

0 Bookmarks
 · 
124 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Uso de antagonistas de aldosterona para detener la progresión de la enfermedad renal: de las bases fi siológicas a la aplicación clínica Sistema renina-angiotensina-aldosterona; Eplerenona; Espironolactona; Receptor de mineralocorticoides; Progresión de daño renal; Nefropatía crónica Resumen La aldosterona, sintetizada en la zona glomerulosa de la corteza suprarrenal, es la principal hormona reguladora del metabolismo de sodio y potasio y del volumen extracelular. A través del receptor de mineralocorticoides, actúa como la señal endocrina fi nal del sistema renina-angiotensina-aldosterona sobre el epitelio del túbulo renal y del colon distal, que estimu-la la reabsorción de sodio y la secreción de potasio. El agua se reabsorbe, vía ósmosis, favore-ciendo la expansión del volumen circulante y, por ende, incrementando la presión arterial. Recientemente, se ha centrado el interés en las acciones no clásicas de la aldosterona sobre el endotelio vascular, corazón y riñón. Existe evidencia de que la aldosterona está involucrada en la remodelación vascular, la función endotelial y la formación de colágena, y que contribuye a la progresión de la insufi ciencia cardiaca, así como del daño renal. Se revisa la evidencia clínica y experimental que fundamenta el uso de bloqueadores de aldosterona para detener la progresión del daño renal en diferentes modelos. © 2013 Hospital Infantil de México Federico Gómez. Publicado por Masson Doyma México S.A. Todos los derechos reservados. Documento descargado de http://zl.elsevier.es el 20/08/2014. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato. 138 M. Medeiros et al.
    Bol Med Hosp Infant Mex. 01/2014; 71(3):1665-1146.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent advances have identified the podocyte as a key target in glomerular injury. The podocyte is a highly specialized cell which is responsible for the glomerular permselectivity for proteins in the kidney. Podocyte injury or loss leads to proteinuria. Apoptosis has been shown to contribute to renal cell loss, including loss of podocytes. The most striking feature of the podocyte is its ability to form intricate specialized cell junctions, the slit diaphragm. Slit diaphragm proteins play an important role in podocyte biology, protein permselectivity, cell signalling and disease. This review focuses on recent advances on the understanding of podocyte survival regulation, its relationship to slit diaphragm structure and function, and how this knowledge may affect our therapeutic approach to proteinuric kidney disease.
    Current Medicinal Chemistry 02/2008; 15(16):1645-54. · 3.72 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic kidney disease (CKD) occurs in all age groups, including children. Regardless of the underlying cause, CKD is characterized by progressive scarring that ultimately affects all structures of the kidney. The relentless progression of CKD is postulated to result from a self-perpetuating vicious cycle of fibrosis activated after initial injury. We will review possible mechanisms of progressive renal damage, including systemic and glomerular hypertension, various cytokines and growth factors, with special emphasis on the renin-angiotensin-aldosterone system (RAAS), podocyte loss, dyslipidemia and proteinuria. We will also discuss possible specific mechanisms of tubulointerstitial fibrosis that are not dependent on glomerulosclerosis, and possible underlying predispositions for CKD, such as genetic factors and low nephron number.
    Pediatric Nephrology 01/2008; 22(12):2011-22. · 2.88 Impact Factor

Full-text (2 Sources)

Download
8 Downloads
Available from
Aug 14, 2014